BRWM
ABEO icon

B. Riley Wealth Management’s Abeona Therapeutics ABEO Stock Holding History

B. Riley Wealth Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$3 Buy
+516
New +$2.61K ﹤0.01% 754

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

B. Riley Wealth Management's ABEO Position: Q2 2022 in Review

B. Riley Wealth Management opened a new position in Abeona Therapeutics (ABEO) in Q2 2022: 516 shares worth $3. The stake represents ﹤0.01% of the portfolio and ranks #754 among its holdings.

42 funds tracked by Wall St. Rank hold ABEO as of Q2 2022.

  • B. Riley Wealth Management held 516 shares of Abeona Therapeutics worth $3 as of Q2 2022.
  • Abeona Therapeutics was a new B. Riley Wealth Management position in Q2 2022.
  • Abeona Therapeutics made up ﹤0.01% of B. Riley Wealth Management's portfolio in Q2 2022, its #754 holding.
  • 42 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.